S2658Referred to Committee

Medication Affordability and Patent Integrity Act

Share:
Introduced
In Committee
3
Passed One Chamber
4
Passed Both
5
Signed into Law
119th
Congress
2025-08-01
Introduced
1
Cosponsors
S
ⓘ
Type

Sponsor

Margaret Wood Hassan
Margaret Wood Hassan
Democrat · NH · Senator
Votes with party: 49.1% (324 recorded votes)

Full profile: /officials/H001076

Source: Congress.gov · FEC

Cosponsors (1)

Members who have signed on to support this bill since introduction. Source: Congress.gov.

Latest Action

The most recent step in the bill's legislative path. Committee Activity below shows referrals and reports; the full action-by-action history including floor proceedings lives at Congress.gov →

Committee on Health, Education, Labor, and Pensions. Hearings held.

2026-03-19

Source: Congress.gov

Plain-English Summary

This bill would allow the federal government to negotiate drug prices directly with pharmaceutical companies for Medicare patients, while also limiting how long companies can extend their patent protections to keep generic competitors off the market. The changes would aim to lower medication costs for seniors and other patients, though drug manufacturers would face reduced profits from their patents. The bill affects pharmaceutical companies, Medicare beneficiaries, and patients who rely on prescription medications.

AI-assisted summary generated from the official bill metadata (title, subjects, actions) sourced from Congress.gov. Cached and reviewed. Always verify against the official text linked below.

Subjects

Commerce
Full bill text is not yet cached locally.
Open text viewRead on Congress.gov

Related legislation

Bills by the same sponsor or covering overlapping subjects.